DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $873,000 | +8.0% | 2,653 | 0.0% | 0.55% | -2.3% |
| Q3 2021 | $808,000 | +13.5% | 2,653 | 0.0% | 0.56% | +49.5% |
| Q2 2021 | $712,000 | +19.3% | 2,653 | 0.0% | 0.38% | +10.6% |
| Q1 2021 | $597,000 | +1.2% | 2,653 | 0.0% | 0.34% | -10.1% |
| Q4 2020 | $590,000 | -71.3% | 2,653 | -72.2% | 0.38% | -70.2% |
| Q3 2020 | $2,053,000 | +21.8% | 9,531 | 0.0% | 1.27% | +7.8% |
| Q2 2020 | $1,685,000 | +27.7% | 9,531 | 0.0% | 1.18% | -4.7% |
| Q1 2020 | $1,319,000 | -9.8% | 9,531 | 0.0% | 1.24% | +26.0% |
| Q4 2019 | $1,463,000 | +6.2% | 9,531 | 0.0% | 0.98% | -0.5% |
| Q3 2019 | $1,377,000 | +1.1% | 9,531 | 0.0% | 0.98% | -1.8% |
| Q2 2019 | $1,362,000 | +8.3% | 9,531 | 0.0% | 1.00% | +4.5% |
| Q1 2019 | $1,258,000 | +28.0% | 9,531 | 0.0% | 0.96% | +7.6% |
| Q4 2018 | $983,000 | -5.0% | 9,531 | 0.0% | 0.89% | +15.8% |
| Q3 2018 | $1,035,000 | +10.0% | 9,531 | 0.0% | 0.77% | +2.9% |
| Q2 2018 | $941,000 | +0.9% | 9,531 | 0.0% | 0.75% | -5.6% |
| Q1 2018 | $933,000 | +5.4% | 9,531 | 0.0% | 0.79% | +17.2% |
| Q4 2017 | $885,000 | +8.2% | 9,531 | 0.0% | 0.68% | -5.1% |
| Q3 2017 | $818,000 | +1.7% | 9,531 | 0.0% | 0.71% | -2.1% |
| Q2 2017 | $804,000 | -1.3% | 9,531 | 0.0% | 0.73% | +10.0% |
| Q1 2017 | $815,000 | +9.8% | 9,531 | 0.0% | 0.66% | -5.7% |
| Q4 2016 | $742,000 | -0.7% | 9,531 | 0.0% | 0.70% | -5.3% |
| Q3 2016 | $747,000 | -55.1% | 9,531 | -42.1% | 0.74% | -45.0% |
| Q2 2016 | $1,663,000 | -65.6% | 16,461 | -67.7% | 1.35% | -34.3% |
| Q1 2016 | $4,828,000 | -43.2% | 50,899 | -44.4% | 2.05% | -23.9% |
| Q4 2015 | $8,498,000 | -50.3% | 91,496 | -54.4% | 2.69% | +8.1% |
| Q3 2015 | $17,113,000 | -13.6% | 200,834 | -13.2% | 2.49% | +8.8% |
| Q2 2015 | $19,806,000 | -57.0% | 231,403 | -57.4% | 2.29% | -7.6% |
| Q1 2015 | $46,091,000 | +30.0% | 542,885 | +31.3% | 2.48% | +39.8% |
| Q4 2014 | $35,448,000 | – | 413,580 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |